KIORA PHARMACEUTICALS, INC. (KPHMW) Operating cash flow 2016–2025
KIORA PHARMACEUTICALS, INC. (KPHMW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$10.0MFY2025 · since FY2016: -$8.4M → -$10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.0M | -216.4% |
| FY2024 | $8.6M | +189.6% |
| FY2023 | -$9.6M | +8.4% |
| FY2022 | -$10.4M | +2.3% |
| FY2021 | -$10.7M | -45.9% |
| FY2020 | -$7.3M | +10.3% |
| FY2019 | -$8.2M | +24.8% |
| FY2018 | -$10.8M | -67.7% |
| FY2017 | -$6.5M | +23.1% |
| FY2016 | -$8.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KPHMW financial trends
KPHMW RevenueKPHMW Net incomeKPHMW Net marginKPHMW Gross profitKPHMW Gross marginKPHMW Operating incomeKPHMW Operating marginKPHMW Free cash flowKPHMW Capital expendituresKPHMW Return on equityKPHMW Stock buybacksKPHMW Dividends paidKPHMW Total assetsKPHMW Total liabilitiesKPHMW Shareholders’ equityKPHMW overview →